Medivolve Announces Change of Auditor
TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP ("MNP") to MS Partne
Press Release: Medivolve Announces Telehealth Platform Development Contract and Change of Officers and Directors
Medivolve Announces Telehealth Platform Development Contract and Change of Officers and Directors TORONTO, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (NEO: MEDV;
Medivolve Announces Change of Auditor and Board Changes
TORONTO, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (NEO: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from McGovern Hurley LLP ("McGovern")
Press Release: Medivolve Announces Board Changes
Medivolve Announces Board Changes TORONTO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (NEO: MEDV; OTC: MEDVF; FRA:4NC) announces today that Dr. Beverley Richardso
Press Release: Medivolve Announces Results of Annual and Special Shareholder Meeting
Medivolve Announces Results of Annual and Special Shareholder Meeting TORONTO, June 22, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (NEO: MEDV; OTC: MEDVF; FRA:4NC) reports
Medivolve Achieves Significant Milestone by Establishing Management Services Organization
TORONTO, May 15, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (NEO: MEDV; OTC: MEDVF; FRA: 4NC) is pleased to announce that it has established Medivolve Management Services
Medivolve to Host Live Webinar to Discuss Corporate Update
TORONTO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (NEO: MEDV; OTC: MEDVF; FRA: 4NC) is pleased to announce that it will be hosting a corporate update presentat
Medivolve Announces Private Placement Financing of up to $4 Million
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (NEO:MEDV;
Medivolve Closes Previously Announced CAN $1.2 Million Convertible Note Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (NEO: MEDV;
Medivolve Announces CAN $1.2 Million Convertible Note Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 23, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (NEO:MEDV;
Medivolve to Consolidate Shares on 1-for-15 Basis
Medivolve to Implement Share Consolidation
TORONTO, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (NEO: MEDV; OTC: MEDVF; FRA: 4NC) will consolidate its common shares on the basis of one new common share for
Medivolve Pivoting Towards Expansion of Service Offerings and Other Updates
TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (NEO: MEDV) (OTC: COPRF) (FRA: 4NC), a healthcare technology and services company, has began its transition t
Medivolve Announces Launch of Investor Awareness Campaign and Refiling of Q2 2022 Financial Statements
TORONTO, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (NEO: MEDV; OTC: COPRF; FRA: 4NC) is pleased to announce the launch of an investor marketing campaign to rais
Medivolve Reports 1H Results
Medivolve press release (OTCPK:COPRF): 1H net loss was $7.41M in the six months ended June 30, 2022, compared to $18.68M over the prior six months ended June 30, 2021. An increase of 5,056%, cash on
Medivolve Announces Q2 2022 Financial Results
TORONTO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (NEO: MEDV; OTC: COPRF; FRA: 4NC), a healthcare technology company that seeks to improve the US healthcare sy
Medivolve Provides Update on its Mobile Clinic Network
TORONTO, July 26, 2022 (GLOBE NEWSWIRE) -- Medivolve Inc. ("Medivolve" or the "Company") (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare technology and services company, is pleased to provide an update
Medivolve Announces Results of Annual and Special Shareholder Meeting
TORONTO, June 16, 2022 (GLOBE NEWSWIRE) -- Medivolve, Inc. ("Medivolve" or the "Company") (NEO: MEDV; OTC: COPRF; FRA:4NC), reports, in accordance with the policies of the NEO Exchange, that the nom
Medivolve reports Q1 results
Medivolve press release (OTCPK:COPRF): Q1 gross profit was $6.41M in the three months ending March 31, 2022, up 518%, compared to $1.05M over the prior three months ending March 31, 2021. Net loss wa
Medivolve Announces Q1 2022 Financial Results
Cash on hand was $8,327,812 as at March 31, 2022, up 7,309% compared to $112,397 as at December 31, 2021.Cash provided by operating activities was $8,211,415 in the three months ending March 31, 2022,
No Data